ICD-10-CM Billable Code

C17.9

Malignant neoplasm of small intestine, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the small intestine, classified under the ICD-10 code C17.9, refers to a cancerous growth that originates in the small intestine but where the exact location within the small intestine is not specified. The small intestine is a crucial part of the digestive system, responsible for nutrient absorption. Though cancers in this area are relatively rare compared to other gastrointestinal cancers, they pose significant health concerns. Recognizing the nature, symptoms, and potential treatments of this condition can aid in early diagnosis and management.

Causes & Symptoms

Clinical Causes: Genetic predisposition, such as hereditary syndromes like familial adenomatous polyposis (FAP) or Lynch syndrome Chronic inflammation of the small intestine, including Crohn's disease and celiac disease Exposure to certain carcinogens through diet or environment Previous radiation therapy to abdominal areas Dietary factors, such as diets high in processed or smoked foods Personal history of other gastrointestinal cancers

Key Symptoms: Unexplained weight loss Abdominal pain or cramping Nausea and vomiting Blood in stool or gastrointestinal bleeding Changes in bowel habits, such as diarrhea or constipation A palpable mass in the abdomen Fatigue and weakness due to anemia or nutritional deficiencies

Diagnostic & Treatment

Diagnosis Path: Diagnosing a malignant neoplasm of the small intestine involves multiple steps to confirm the presence of cancer and determine its extent. These include: - **Medical history and physical examination:** Physicians gather information about symptoms and risk factors. - **Imaging tests:** Techniques such as CT scans, MRI, or ultrasound help visualize the tumor. - **Endoscopy:** Procedures like capsule endoscopy or enteroscopy allow visualization of the small intestine and biopsy collection. - **Biopsy:** Tissue samples obtained during endoscopy are examined microscopically to confirm malignancy. - **Laboratory tests:** Blood tests may reveal anemia or markers indicative of cancer. - **Additional tests:** PET scans can assess the spread or metastasis of cancer cells. Early diagnosis relies heavily on a combination of these diagnostic tools, which aid physicians in staging the disease and planning appropriate management.

Treatment Protocols: Treatment approaches for malignant neoplasm of the small intestine depend on factors like tumor size, location, stage, and the patient's overall health. Common options include: - **Surgical removal:** The primary treatment, aiming to excise the tumor and affected surrounding tissue. - **Chemotherapy:** Use of anticancer drugs to kill cancer cells or shrink tumors, often employed in advanced stages or after surgery. - **Radiation therapy:** Targeted radiation may be used to eliminate residual cancer cells, though its role is limited due to the small intestine’s sensitivity. - **Targeted therapy:** In select cases, therapies that target specific genetic mutations or proteins can be effective. - **Supportive care:** Includes managing symptoms, nutritional support, and treatment of side effects. Multidisciplinary care involving oncologists, gastroenterologists, and surgeons is essential to optimize patient outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C17.9 a billable ICD-10 code?
Yes, C17.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C17.9?
Clinical documentation must specify the nature of Malignant neoplasm of small intestine, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

small neoplasm malignant